Pune, India

Firoj Aftab Raje

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Lupin, Inc.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Firoj Aftab Raje. Retrieved from https://idiyas.com/inventor/firoj-aftab-raje

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Firoj Aftab Raje: Innovator in Pharmaceutical Chemistry

Introduction

Firoj Aftab Raje is a notable inventor based in Pune, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for therapeutic use. His work focuses on addressing critical health issues through innovative solutions.

Latest Patents

Firoj Aftab Raje holds a patent for "Thiazole derivatives as alpha 7 nAChR modulators." This patent discloses a compound of formula (I) that acts as a modulator of nicotinic acetylcholine receptors, specifically the α7 subtype. The invention includes pharmaceutically acceptable salts, polymorphs, solvates, and isomers for therapeutic applications. The compounds are intended for use in the prophylaxis and therapy of disorders such as Alzheimer's disease, mild cognitive impairment, and senile dementia.

Career Highlights

Firoj Aftab Raje is currently associated with Lupin, Inc., where he continues to advance his research and development efforts. His work has led to the creation of innovative pharmaceutical solutions that aim to improve patient outcomes.

Collaborations

Firoj collaborates with esteemed colleagues, including Neelima Sinha and Venkata Poornapragnacharyulu Palle. These partnerships enhance the research environment and contribute to the success of their projects.

Conclusion

Firoj Aftab Raje exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborative efforts are paving the way for advancements in therapeutic treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…